Table 5:
Screening studies that included at least 100 study participants
| First author | Year | Total number of participants | Primary mode of screening | Number of PDACs | Surgically resected PDACS | Surgeries for high-grade dysplasia | Surgeries for benign/low-risk lesions | Reference |
|---|---|---|---|---|---|---|---|---|
| Al-Sukhni | 2012 | 262 | MRI | 3 | 1 | 0 | 2 | [123] |
| Canto | 2018 | 354 | EUS, CT, MRI | 14 | 10 | 10 | 23 | [120] |
| Dbouk | 2022 | 1461 | EUS, CT, MRI | 10 | 8 | 3 | 5 | [9] Overlap with Canto (2018) |
| Harinck | 2016 | 139 | EUS, MRI | 1 | 1 | 0 | 1 | [131] |
| Klatte | 2022 | 347 | MRI, EUS | 36 | 27 | 0 | 8 | [122] Overlap with Vasen (2016) |
| Konings | 2017 | 186 | MRI, EUS | 2 | 1 | 0 | 2 | [223] |
| Lachter | 2018 | 123 | EUS | 1 | 1 | 0 | 0 | [224] |
| Ludwig | 2011 | 109 | MRI, EUS | 1 | 1 | 1 | 4 | [225] |
| Overbeek | 2022 | 366 | MRI, EUS | 10 | 6 | 0 | 8 | [121] |
| Paiella | 2019 | 187 | MRI, EUS | 5 | 2 | 0 | 2 | [226] |
| Vasen | 2016 | 411 | MRI, EUS | 15 | 11 | 4 | 14 | [125] |
| Zubarik | 2011 | 546 | CA19–9, EUS | 1 | 1 | 0 | 1 | [124] |
CT=computed tomography, EUS=endoscopic ultrasound, MRI= magnetic resonance imaging, PDAC= pancreatic ductal adenocarcinoma